Llavado, Noralyn .

HRN: 21-70-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2022
CEFUROXIME 1.5GM (VIAL)
08/19/2022
08/26/2022
IVT
1.5g
Q8
For Diagnostic D&C
Waiting Final Action 
08/20/2022
CO-AMOXICLAV 625MG (TAB)
08/20/2022
08/27/2022
PO
625mg
BID X 7 Days
S/P Fractional Curettage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: